CDC A(H5N1) Bird Flu Response Update February 26, 2025; Confirmed 3 Human Cases Of H5 Bird Flu In People Who Became Ill In 2025 - Website
Institutional Investors May Overlook Novavax, Inc.'s (NASDAQ:NVAX) Recent US$135m Market Cap Drop as Long-term Gains Remain Positive
TD Cowen Initiates Novavax(NVAX.US) With Hold Rating, Announces Target Price $9
Novavax: Promising Innovations Amidst Execution and Competitive Challenges – Hold Rating
Novavax Inc. Stock Slips 7.3%, Underperforms Competitors
What's in Store for These 5 Biotech Stocks This Earnings Season?
Earnings Preview: Novavax to Report Financial Results Pre-market on February 27
Novavax Call Volume Above Normal and Directionally Bullish
Deregulation Exposure Was the Most Valuable Characteristic of a Stock Owned by Hedge Funds – GS
Novavax (NVAX) Declines More Than Market: Some Information for Investors
First Meeting of CDC Vaccine Advisory Panel Under RFK Jr. Postponed
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025
Novavax to Report Q4 Earnings: Here's What You Can Expect
Express News | Trump Order Halts Funding For School Covid Vaccine Mandates
'Make America Healthy Again' Platform to Be a Top Priority of RFK Jr. at HHS
Express News | U.S. CDC Report: Evidence Found Of Recent Bird Flu Infections Among 3 Cattle Veterinarians
BofA Securities Maintains Novavax(NVAX.US) With Hold Rating, Maintains Target Price $12
Bank of America Securities Sticks to Its Hold Rating for Novavax (NVAX)
(NVAX) - Analyzing Novavax's Short Interest